Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Community Studies to Monitor the Impact of Triple Drug Therapy Relative to Double Drug Therapy on Lymphatic Filariasis Infection Indicators

NCT03352206 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT03352206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03352206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Community Studies to Monitor the Impact of Triple Drug Therapy Relative to Double Drug Therapy on Lymphatic Filariasis Infection Indicators
Lead sponsor
Washington University School of Medicine
Phase
Observational
Overall status
Completed
Start date
October 18, 2017
Completion date
November 1, 2019
Enrollment
20,092 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic filariases